A detailed history of Provence Wealth Management Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Provence Wealth Management Group holds 2,801 shares of LLY stock, worth $2.21 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
2,801
Previous 2,386 17.39%
Holding current value
$2.21 Million
Previous $1.28 Million 27.4%
% of portfolio
0.88%
Previous 0.79%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$525.19 - $619.13 $217,953 - $256,938
415 Added 17.39%
2,801 $1.63 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $96,938 - $133,643
223 Added 10.31%
2,386 $1.28 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $115,744 - $154,763
330 Added 18.0%
2,163 $1.01 Million
Q1 2023

Apr 26, 2023

BUY
$310.63 - $364.82 $130,153 - $152,859
419 Added 29.63%
1,833 $629,000
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $454,671 - $529,783
1,414 New
1,414 $517,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Provence Wealth Management Group Portfolio

Follow Provence Wealth Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provence Wealth Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Provence Wealth Management Group with notifications on news.